Orange Book product · Brand (NDA)
SODIUM NITROPRUSSIDE
SODIUM NITROPRUSSIDE
At a glance
Jul 28, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 28, 1982
44 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
SODIUM NITROPRUSSIDE
Strength
50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
NDA 018581
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2017NIPRIDE RTU IN SODIUM CHLORIDE 0.9%Brand (NDA)
NDA 209387 · EXELA PHARMA
- —NIPRIDEBrand (NDA)
NDA 017546 · ROCHE
- —NITROPRESSBrand (NDA)
NDA 018450 · ABBVIE
- 2022SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 208923 · AVET LIFESCIENCES
- 2022SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 215846 · SLATE RUN PHARMA
- 2021SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 214971 · BE PHARMS
- 2020SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 211934 · EUGIA PHARMA
- 2020SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 211277 · XIROMED
- 2020SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 214199 · SLATE RUN PHARMA
- 2019SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 211016 · CAPLIN
- 2019SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 210114 · DR REDDYS
- 2018SODIUM NITROPRUSSIDEGeneric (ANDA)
ANDA 210467 · SUN PHARM
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
